FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

96 results

abrilada
(adalimumab-afzb)
Pfizer Laboratories Div Pfizer Inc
Usage: ABRILADA is indicated for the treatment of various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, moderate to severe chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and certain pediatric patients.
abrilada
(adalimumab-afzb)
Pfizer Laboratories Div Pfizer Inc
Usage: ABRILADA is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients.
acitretin
(ACITRETIN)
Sigmapharm Laboratories, LLC
Usage: Acitretin Capsules, USP are indicated for the treatment of severe psoriasis in adults. They should only be prescribed by those skilled in systemic retinoid use, especially for non-pregnant females of reproductive potential unresponsive to other therapies, due to significant adverse effects and potential birth defects.
acitretin
(Acitretin)
Amneal Pharmaceuticals of New York LLC
Usage: Acitretin capsules are indicated for treating severe psoriasis in adults, particularly when other therapies fail or are contraindicated. Due to significant adverse effects, only those familiar with systemic retinoids should prescribe it, and it poses risks of severe birth defects in women of reproductive potential.
adalimumab
(adalimumab-fkjp)
Biocon Biologics Inc
Usage: Adalimumab-fkjp is indicated for treating moderate to severe rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients (ages vary by condition).
adalimumab
(adalimumab-adaz)
Sandoz Inc
Usage: Adalimumab-adaz is indicated for adults with moderate to severe chronic plaque psoriasis who require systemic therapy or phototherapy, and when other systemic treatments are less suitable. Patients must be closely monitored and have regular physician follow-ups.
adalimumab-ryvk
(adalimumab-ryvk)
Quallent Pharmaceuticals Health LLC
Usage: Adalimumab-ryvk is indicated for various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis, aiming to reduce symptoms and inhibit disease progression.
amjevita
(adalimumab-atto)
Optum Health Solutions (Ireland) Limited
Usage: AMJEVITA is indicated for various conditions including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis, either alone or in combination with other therapies.
apremilast
(APREMILAST)
Amneal Pharmaceuticals NY LLC
Usage: Apremilast tablets are indicated for treating adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
bimzelx
(bimekizumab)
UCB, Inc.
Usage: BIMZELX is used to treat moderate to severe plaque psoriasis, active psoriatic arthritis, active non-radiographic axial spondyloarthritis with inflammation, active ankylosing spondylitis, and moderate to severe hidradenitis suppurativa in adults who qualify for systemic therapy or phototherapy.

Medications for Psoriasis

abrilada

abrilada

acitretin

acitretin

adalimumab

adalimumab

adalimumab-ryvk

amjevita

apremilast

bimzelx